KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Change in Cash (2016 - 2025)

Eli Lilly (LLY) has disclosed Change in Cash for 17 consecutive years, with -$2.5 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash fell 2388.66% year-over-year to -$2.5 billion, compared with a TTM value of $4.0 billion through Dec 2025, up 790.87%, and an annual FY2025 reading of $4.0 billion, up 790.87% over the prior year.
  • Change in Cash was -$2.5 billion for Q4 2025 at Eli Lilly, down from $6.4 billion in the prior quarter.
  • Across five years, Change in Cash topped out at $6.4 billion in Q3 2025 and bottomed at -$2.5 billion in Q4 2025.
  • Average Change in Cash over 5 years is $180.5 million, with a median of $12.4 million recorded in 2021.
  • The sharpest move saw Change in Cash plummeted 5603.64% in 2023, then soared 4312.65% in 2025.
  • Year by year, Change in Cash stood at $30.3 million in 2021, then tumbled by 1916.5% to -$550.4 million in 2022, then surged by 179.61% to $438.2 million in 2023, then crashed by 123.14% to -$101.4 million in 2024, then tumbled by 2388.66% to -$2.5 billion in 2025.
  • Business Quant data shows Change in Cash for LLY at -$2.5 billion in Q4 2025, $6.4 billion in Q3 2025, and $282.6 million in Q2 2025.